Front Row Spotlight: Jeff Kelly @ScrippsResearch
Front Row Spotlight: Jeff Kelly  @ScrippsResearch
Uploaded May 2024 | Updated September 2026, 48 minutes ago
Scripps Research scientist Prof. Jeffery Kelly received an unexpected visit from a patient whose life was dramatically improved by tafamidis—a revolutionary drug for treating neurodegenerative and heart diseases, developed by Kelly himself. Kelly is a leading figure at Scripps Research, spearheading efforts to address some of the most pressing medical challenges, including Alzheimer’s and various amyloid diseases. His cutting-edge research on protein misfolding has not only led to the development of tafamidis but has also broadened our understanding of protein aggregation disorders.

Join us for an upcoming Front Row lecture where Kelly will explore his groundbreaking work on protein misfolding diseases, which has uncovered key information in the fight against conditions like dementia and heart failure.

Register now for in-person and virtual spots at https://frontrow.scripps.edu/lectures/kelly/?utm_source=youtube&utm_campaign=event-frontrow-kelly-20240515&utm_medium=organic&utm_content=video

Subscribe for more inspiring stories of how Scripps Research scientists are changing lives through groundbreaking science!

https://www.scripps.edu/
Front Row Spotlight: Jeff KellyJay Pandit: How biosensors are enabling a new era in medicineA Science Institute for the 21st Century | Scripps ResearchNew Regenerative Lung Therapy Begins Phase 1 Trials | CMR316 & IPF TreatmentBruce Wilkoff: A pioneering cardiologist who dedicated his career to preventing sudden deathBringing precision therapy to mental disordersAl Gore: The Intersection of A.I. and Climate ChangeBioengineering our way out of climate change: Ahmed Badran podcast highlightsImmunoCARE Study: Fast, accurate COVID-19 testing to reduce hospitalization of vulnerable peopleIf AI can pass the bar, can it be a lawyer? #shortsInspiring the Next Generation of Scientific Leaders | Scripps ResearchBiotech Innovation Summit 2025 | Scripps Research
Scripps Research |

Front Row Spotlight: Jeff Kelly

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER